Ledger.Open graph →
SEC Form D · filed May 7, 2020

Paragon Biosciences Evozyne Capital, LLC

Offering
$9.5M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHICAGO, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Darien J. Parhad · Chicago, ILExecPatrick J. Morris · Chicago, ILExec · DirectorRobert L. Rainhart · Herndon, VAExec · DirectorMark L. Spoto · Herndon, VAExecMahesh Gehani · Dallas, TXExecHenning Bruder · Grand Cayman, Cayman IslandsExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗